knowledge -WSS

knowledge

author：comprehensive 2025-09-07 11:15:12 - browse：9377

Has AI really solved biology? What can machines teach us about medicine? And what’s a digital twin?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. It’s our all-AI episode. First, STAT’s Casey Ross joins us to explain his reporting on how researchers and pharmaceutical firms are using the technology to find new drug targets, design therapies, and improve clinical trials. Then, we talk to Joel Dudley, a partner at the venture firm Innovation Endeavors, about how to discern promising ideas from wastes of time when it comes to AI in biotech.

For more on what we cover, here’s the latest on AI in drug development; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

WSS

Antibiotic resistance and the global rise in human conflict

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Oprah kicked off a national conversation on obesity. Let's have it

States should stop sabotaging methadone treatment reform

Steward Health Care has deal to sell doctor network to UnitedHealth

3 medical device trends to watch in 2024

knowledge

knowledge

hotspot

Medical leaders decry Supreme Court decision on affirmative action

Patient advocates debate FDA's accelerated approval process

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

3 trends to watch in health tech's hiring outlook for 2024

New air purifier tech could be key to improving indoor air quality

Supreme Court mifepristone arguments center on docs' right to sue

BioMarin wins approval for gene therapy to treat hemophilia A

GSK Flovent asthma inhalers replaced by authorized generics

Heart attack and stroke risk calculators need revising

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

knowledge

Covid vaccine financial winners and losers, from Pfizer to Novavax

Abortion pill Supreme Court ruling could impact entire drug industry

Chronically ill young patients struggle to find fertility info

JPM: CVS says Medicare Advantage patients are impacting profits

UCB departs biotech trade group BIO

Goldman Sachs launches $650M fund for life science investments

focus

hotspot

hotspot

hotspot